150 related articles for article (PubMed ID: 18182995)
1. Profiling influences of senescent and aged fibroblasts on prostate carcinogenesis.
Dean JP; Nelson PS
Br J Cancer; 2008 Jan; 98(2):245-9. PubMed ID: 18182995
[TBL] [Abstract][Full Text] [Related]
2. Profiling molecular targets of TGF-beta1 in prostate fibroblast-to-myofibroblast transdifferentiation.
Untergasser G; Gander R; Lilg C; Lepperdinger G; Plas E; Berger P
Mech Ageing Dev; 2005 Jan; 126(1):59-69. PubMed ID: 15610763
[TBL] [Abstract][Full Text] [Related]
3. The gene expression program of prostate fibroblast senescence modulates neoplastic epithelial cell proliferation through paracrine mechanisms.
Bavik C; Coleman I; Dean JP; Knudsen B; Plymate S; Nelson PS
Cancer Res; 2006 Jan; 66(2):794-802. PubMed ID: 16424011
[TBL] [Abstract][Full Text] [Related]
4. Characterization of epithelial senescence by serial analysis of gene expression: identification of genes potentially involved in prostate cancer.
Untergasser G; Koch HB; Menssen A; Hermeking H
Cancer Res; 2002 Nov; 62(21):6255-62. PubMed ID: 12414655
[TBL] [Abstract][Full Text] [Related]
5. Gene expressional changes in prostate fibroblasts from cancerous tissue.
Reinertsen T; Halgunset J; Viset T; Flatberg A; Haugsmoen LL; Skogseth H
APMIS; 2012 Jul; 120(7):558-71. PubMed ID: 22716211
[TBL] [Abstract][Full Text] [Related]
6. Integrated gene and miRNA expression analysis of prostate cancer associated fibroblasts supports a prominent role for interleukin-6 in fibroblast activation.
Doldi V; Callari M; Giannoni E; D'Aiuto F; Maffezzini M; Valdagni R; Chiarugi P; Gandellini P; Zaffaroni N
Oncotarget; 2015 Oct; 6(31):31441-60. PubMed ID: 26375444
[TBL] [Abstract][Full Text] [Related]
7. Identification of SFRP1 as a candidate mediator of stromal-to-epithelial signaling in prostate cancer.
Joesting MS; Perrin S; Elenbaas B; Fawell SE; Rubin JS; Franco OE; Hayward SW; Cunha GR; Marker PC
Cancer Res; 2005 Nov; 65(22):10423-30. PubMed ID: 16288033
[TBL] [Abstract][Full Text] [Related]
8. Novel expression of CST1 as candidate senescence marker.
Keppler D; Zhang J; Bihani T; Lin AW
J Gerontol A Biol Sci Med Sci; 2011 Jul; 66(7):723-31. PubMed ID: 21636832
[TBL] [Abstract][Full Text] [Related]
9. The senescence pathway in prostatic carcinogenesis.
Sharma S; Shin JS; Grimshaw M; Clarke RA; Lee CS
Pathology; 2010; 42(6):507-11. PubMed ID: 20854067
[TBL] [Abstract][Full Text] [Related]
10. Senescent fibroblasts drive ageing pigmentation: A potential therapeutic target for senile lentigo.
Yoon JE; Kim Y; Kwon S; Kim M; Kim YH; Kim JH; Park TJ; Kang HY
Theranostics; 2018; 8(17):4620-4632. PubMed ID: 30279727
[TBL] [Abstract][Full Text] [Related]
11. A bioengineered microenvironment to quantitatively measure the tumorigenic properties of cancer-associated fibroblasts in human prostate cancer.
Clark AK; Taubenberger AV; Taylor RA; Niranjan B; Chea ZY; Zotenko E; Sieh S; Pedersen JS; Norden S; Frydenberg M; Grummet JP; Pook DW; ; Stirzaker C; Clark SJ; Lawrence MG; Ellem SJ; Hutmacher DW; Risbridger GP
Biomaterials; 2013 Jul; 34(20):4777-85. PubMed ID: 23562048
[TBL] [Abstract][Full Text] [Related]
12. Cancer, aging and cellular senescence.
Campisi J
In Vivo; 2000; 14(1):183-8. PubMed ID: 10757076
[TBL] [Abstract][Full Text] [Related]
13. Control of tumor and microenvironment cross-talk by miR-15a and miR-16 in prostate cancer.
Musumeci M; Coppola V; Addario A; Patrizii M; Maugeri-Saccà M; Memeo L; Colarossi C; Francescangeli F; Biffoni M; Collura D; Giacobbe A; D'Urso L; Falchi M; Venneri MA; Muto G; De Maria R; Bonci D
Oncogene; 2011 Oct; 30(41):4231-42. PubMed ID: 21532615
[TBL] [Abstract][Full Text] [Related]
14. RNAi-mediated silencing of Myc transcription inhibits stem-like cell maintenance and tumorigenicity in prostate cancer.
Civenni G; Malek A; Albino D; Garcia-Escudero R; Napoli S; Di Marco S; Pinton S; Sarti M; Carbone GM; Catapano CV
Cancer Res; 2013 Nov; 73(22):6816-27. PubMed ID: 24063893
[TBL] [Abstract][Full Text] [Related]
15. Prognostic and therapeutic potential of senescent stromal fibroblasts in prostate cancer.
Mori JO; Elhussin I; Brennen WN; Graham MK; Lotan TL; Yates CC; De Marzo AM; Denmeade SR; Yegnasubramanian S; Nelson WG; Denis GV; Platz EA; Meeker AK; Heaphy CM
Nat Rev Urol; 2024 May; 21(5):258-273. PubMed ID: 37907729
[TBL] [Abstract][Full Text] [Related]
16. Senescent cells: SASPected drivers of age-related pathologies.
Ovadya Y; Krizhanovsky V
Biogerontology; 2014 Dec; 15(6):627-42. PubMed ID: 25217383
[TBL] [Abstract][Full Text] [Related]
17. Gene profile of replicative senescence is different from progeria or elderly donor.
Park WY; Hwang CI; Kang MJ; Seo JY; Chung JH; Kim YS; Lee JH; Kim H; Kim KA; Yoo HJ; Seo JS
Biochem Biophys Res Commun; 2001 Apr; 282(4):934-9. PubMed ID: 11352641
[TBL] [Abstract][Full Text] [Related]
18. Biomolecular bases of the senescence process and cancer. A new approach to oncological treatment linked to ageing.
Badiola I; Santaolalla F; Garcia-Gallastegui P; Ana SD; Unda F; Ibarretxe G
Ageing Res Rev; 2015 Sep; 23(Pt B):125-38. PubMed ID: 25847820
[TBL] [Abstract][Full Text] [Related]
19. Role of the stromal microenvironment in carcinogenesis of the prostate.
Cunha GR; Hayward SW; Wang YZ; Ricke WA
Int J Cancer; 2003 Oct; 107(1):1-10. PubMed ID: 12925950
[TBL] [Abstract][Full Text] [Related]
20. FRAR course on laboratory approaches to aging. Cellular aging, in vitro and in vivo.
Tréton JA
Aging (Milano); 1993 Aug; 5(4):291-7. PubMed ID: 8297932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
